Santen Pharmaceutical
4536.T
#3134
Rank
$2.99 B
Marketcap
$7.98
Share price
-2.06%
Change (1 day)
-39.64%
Change (1 year)

P/E ratio for Santen Pharmaceutical (4536.T)

P/E ratio as of December 2022 (TTM): 14.6

According to Santen Pharmaceutical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.6063. At the end of 2021 the company had a P/E ratio of 89.2.

P/E ratio history for Santen Pharmaceutical from 2009 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202189.2176.1%
202032.351.88%
201921.37.61%
201819.8-32.81%
201729.4118.55%
201613.5-55.36%
201530.237.43%
201421.94.32%
201321.017.4%
201217.937.49%
201113.01.34%
201012.9-42.85%
200922.540.27%
200816.0-19.73%
200720.07.08%
200618.73.04%
200518.1

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.